Skip to main content
Clinical Trials/CTRI/2024/07/070649
CTRI/2024/07/070649
Not yet recruiting
Phase 3

An empirical study on the effectiveness of individualized homoeopathicmanagement in cases of type-2 diabetes mellitus. - nil

Mayank Kanubhai Roy0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Mayank Kanubhai Roy
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Mayank Kanubhai Roy

Eligibility Criteria

Inclusion Criteria

  • 1\. Cases pre\-diagnosed or having clinical features of type 2 diabetes
  • 2\. The patients giving their consent to participate in study with minimum
  • six follow ups.
  • 3\. HbA1c level is 6\.5% or Above
  • 4\. Age\- 18 to 58 years and of both sexes.
  • 5\. Patients who are not taking any medication.
  • 6\. Patients who have stopped medication 3 moths before induction.

Exclusion Criteria

  • 1\. Age below 18 years and above 58 years.
  • 2\. Pregnant and lactating patients.
  • 3\. Patient with Serious complication with inflammatory changes.
  • 4\. Cases with less than 6 follow up.
  • 5\. Patient Diagnosed with G6PD deficiency (glucose\-6\-phosphatedehydrogenase
  • deficiency).
  • 6\. Any patient found to be uncooperative during the study.
  • 7\. Unable to Speak Gujarati, Hindi or English.
  • 8\. Patients on any other medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials